Read + Share
Amedeo Smart
Independent Medical Education
Desai A, Petrov J, Hashash JG, Patel H, et al. Use of glucagon-like peptide-1 receptor agonists for type 2 diabetes mellitus and outcomes of inflammatory bowel disease. Aliment Pharmacol Ther 2024 Jun 27. doi: 10.1111/apt.18138.PMID: 38938071
Email
LinkedIn
Privacy Policy